REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
27/04/2021 14:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210427:nBwW5YxLa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 26 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,740,139 1.35% 166,350 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,134 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,818,598 1.41% 179,584 0.14%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 232.5900 USD
Purchase 2 232.4900 USD
Purchase 31 232.5100 USD
Purchase 40 231.6200 USD
Purchase 40 231.4900 USD
Purchase 50 234.2150 USD
Purchase 60 231.4850 USD
Purchase 60 232.2300 USD
Purchase 77 231.5968 USD
Purchase 100 232.7100 USD
Purchase 101 231.6953 USD
Purchase 140 232.5700 USD
Purchase 165 232.7838 USD
Purchase 200 232.2050 USD
Purchase 200 232.1780 USD
Purchase 200 231.5550 USD
Purchase 200 231.5250 USD
Purchase 200 231.2850 USD
Purchase 200 232.2950 USD
Purchase 220 231.5422 USD
Purchase 234 231.2841 USD
Purchase 300 233.0666 USD
Purchase 300 232.3800 USD
Purchase 301 232.3249 USD
Purchase 400 234.2550 USD
Purchase 400 233.6025 USD
Purchase 400 231.7104 USD
Purchase 476 231.4888 USD
Purchase 500 231.5860 USD
Purchase 1,182 231.5395 USD
Purchase 1,267 232.5279 USD
Purchase 1,799 231.9742 USD
Purchase 1,904 231.4404 USD
Purchase 1,943 231.3013 USD
Purchase 3,065 231.2989 USD
Purchase 3,514 232.8533 USD
Purchase 3,667 233.0090 USD
Purchase 4,459 231.5073 USD
Purchase 7,631 231.3036 USD
Purchase 8,201 232.2332 USD
Purchase 8,512 232.2483 USD
Purchase 12,390 231.4430 USD
Purchase 12,495 231.3000 USD
Purchase 34,345 232.7487 USD
Purchase 35,149 232.4947 USD
Sale 1 231.3300 USD
Sale 1 232.8400 USD
Sale 2 231.1450 USD
Sale 37 232.5181 USD
Sale 60 231.4850 USD
Sale 100 234.0900 USD
Sale 100 234.1700 USD
Sale 100 233.9000 USD
Sale 100 233.8600 USD
Sale 108 232.3315 USD
Sale 145 231.2300 USD
Sale 160 233.4637 USD
Sale 400 232.1780 USD
Sale 824 232.1489 USD
Sale 1,267 232.5279 USD
Sale 1,267 232.5280 USD
Sale 1,397 232.4843 USD
Sale 3,214 232.9129 USD
Sale 3,700 232.6842 USD
Sale 4,177 233.2064 USD
Sale 4,574 231.6432 USD
Sale 4,667 232.7525 USD
Sale 7,342 232.2207 USD
Sale 7,729 231.3035 USD
Sale 17,334 231.3000 USD
Sale 20,000 231.4596 USD
Sale 33,971 232.3823 USD
Sale 34,345 232.7486 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 27 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210427005719/en/
(https://www.businesswire.com/news/home/20210427005719/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement